Verona Pharma Valuation
| VRNA Stock | USD 39.63 0.27 0.68% |
At this time, the company appears to be overvalued. Verona Pharma PLC has a current Real Value of $37.85 per share. The regular price of the company is $39.63. Our model measures the value of Verona Pharma PLC from inspecting the company fundamentals such as Shares Owned By Insiders of 4.13 %, return on equity of -0.78, and Current Valuation of 3.03 B as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Verona Pharma's valuation include:
Price Book 24.8521 | Enterprise Value 3 B | Enterprise Value Ebitda (20.89) | Price Sales 576.6306 | Enterprise Value Revenue 538.6272 |
Overvalued
Today
Please note that Verona Pharma's price fluctuation is very steady at this time. Calculation of the real value of Verona Pharma PLC is based on 3 months time horizon. Increasing Verona Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Verona Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verona Stock. However, Verona Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.63 | Real 37.85 | Target 33.14 | Hype 38.33 |
The real value of Verona Stock, also known as its intrinsic value, is the underlying worth of Verona Pharma PLC Company, which is reflected in its stock price. It is based on Verona Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Verona Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Verona Pharma PLC helps investors to forecast how Verona stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verona Pharma more accurately as focusing exclusively on Verona Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Verona Pharma's intrinsic value based on its ongoing forecasts of Verona Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Verona Pharma's closest peers. If more than one evaluation category is relevant for Verona Pharma we suggest using both methods to arrive at a better estimate.
Verona Pharma Cash |
|
Verona Valuation Trend
Comparing Verona Pharma's enterprise value against its market capitalization is a good way to estimate the value of Verona Pharma PLC uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Verona Pharma Total Value Analysis
Verona Pharma PLC is at this time estimated to have valuation of 3.03 B with market capitalization of 3.24 B, debt of 51.33 M, and cash on hands of 111.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Verona Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.03 B | 3.24 B | 51.33 M | 111.51 M |
Verona Pharma Investor Information
About 89.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.0. Verona Pharma PLC had not issued any dividends in recent years. Based on the key measurements obtained from Verona Pharma's financial statements, Verona Pharma PLC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Verona Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Verona Pharma has an asset utilization ratio of 0.15 percent. This suggests that the Company is making $0.001486 for each dollar of assets. An increasing asset utilization means that Verona Pharma PLC is more efficient with each dollar of assets it utilizes for everyday operations.Verona Pharma Ownership Allocation
Verona Pharma PLC shows a total of 81.83 Million outstanding shares. The majority of Verona Pharma PLC outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Verona Pharma to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Verona Pharma PLC. Please pay attention to any change in the institutional holdings of Verona Pharma PLC as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Verona Pharma Profitability Analysis
The company reported the previous year's revenue of 458 K. Net Loss for the year was (54.58 M) with profit before overhead, payroll, taxes, and interest of 112 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Verona Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Verona Pharma and how it compares across the competition.
About Verona Pharma Valuation
The stock valuation mechanism determines Verona Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Verona Pharma. We calculate exposure to Verona Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Verona Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -679.6 K | -645.6 K | |
| Pretax Profit Margin | (134.50) | (141.23) | |
| Operating Profit Margin | (129.92) | (136.42) | |
| Net Loss | (135.00) | (141.75) | |
| Gross Profit Margin | 0.22 | 0.23 |
Verona Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 79.3 M |
Verona Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of Verona Pharma PLC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Verona we look at many different elements of the entity such as Verona's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Verona Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Verona Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Verona Pharma's worth.Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |